Avid Bioservices Inc (CDMO)

[stockaxe]

As I've been saying for awhile, patience here will pay off. The fixation on short-term trading and random short-term prices does nothing except make everyone go crazy. Big picture, this Company should be filling its capacity by late 2025 is my guess. That is a company that will be doing ~$130mm of EBITDA or more, and given market multiples even now and what is being rumored for Catalent, that would put the stock into the $40s. Don't kid yourself though. There will be bumps in the road, maybe a quarter here and there with new bookings that disappoint, etc. But the long-term trend here is still quite strong. Doing that math, this still sets up for 40%+ annualized returns from today's price through 2025.